University of Saint Louis: Objectives General Objective
University of Saint Louis: Objectives General Objective
OBJECTIVES
General Objective
The general objective of this case study is to further explore, assess, understand,
and describe the case of a 42-year-old male patient who was diagnosed with Chronic Kidney
Disease. This study will explain furthermore about the nature of the disease and the factors
that contributes to acquiring the disease. Moreover, it includes the management of the
disease and implementation of the nursing care plan to evaluate its effectiveness to the
patient.
To promote health, reduce risk, and potentially protect patients from disease-related
complications, the author aims to implement well-planned, effective interventions.
Additionally, the author tries to determine whether the interventions will have a positive
impact on the patient's general health or well-being.
Specific Objective
This paper specifically aims to:
● Recognize the etiology of the disease, including the predisposing and precipitating
factors.
● Identify the manifestation and the possible risk.
● Provide the patient’s information, nursing history, functional health patterns, and
physical assessments.
● Explain the Anatomy and physiology of the systems involved and the
pathophysiology of endometriotic cyst.
● Provide a patient-centered, well-organized, and effective nursing care plan and drug
studies.
● Appreciate the uses of drugs used to manage the patient with Chronic Kidney
Disease.
1
University of Saint Louis
Tuguegarao City, Cagayan 3500
INTRODUCTION
Disease Description
Chronic kidney disease, also called chronic kidney failure, involves a gradual loss of kidney
function. When this happens, harmful waste and fluids begin to accumulate in the body,
causing a patient to feel unwell. Moreover, other health problems such as heart disease and
stroke may also arise because of this.
While the kidneys filter wastes and excess fluids from the blood, which are then removed in
the urine, CKD affects both these kidneys at the same time. And while the body has two
kidneys to help filter waste, one is not a “back-up” for the other. They work in unison to
cleanse the body.
When a patient is diagnosed with CKD, it means that both of the kidneys are affected and
cannot filter waste and fluid from the body properly. In the early stages of chronic kidney
disease, the patient might have few signs or symptoms and might not realize it until the
condition is advanced. On the other hand, advanced chronic kidney disease can cause
dangerous levels of fluid, electrolytes and wastes to build up in the body.
CKD has varying levels of seriousness. It usually gets worse over time and if left untreated,
CKD can progress to kidney failure and early cardiovascular disease. Although CKD is
incurable, treatment for chronic kidney disease focuses on slowing the progression of kidney
damage, usually by controlling the cause. But, even controlling the cause might not keep
kidney damage from progressing. Chronic kidney disease can progress to end-stage kidney
failure, which is fatal without artificial filtering (dialysis) or a kidney transplant.
(When the kidneys stop working, dialysis or kidney transplant is needed for survival. Kidney
failure treated with dialysis or kidney transplant is called (ESRD) end-stage renal disease)
RISK FACTORS
Predisposing Factors:
Among the non-modifiable risk factors associated with CKD:
Genetics: a patient may be predisposed to CKD insofar as the risk of end stage
renal disease (ESRD) is three to nine times greater if the patient has a family
member with ESRD
2
University of Saint Louis
Tuguegarao City, Cagayan 3500
Race: African Americans, Hispanics, and American Indians are at high risk for
developing kidney failure. This risk is due in part to high rates of diabetes and high
blood pressure in these communities.
Age: CKD is more common in people aged 65 years or older (38%) than in people
aged 45 to 64 years (13%) or 18 to 44 years (7%).
Low birth weight, which is associated with impaired kidney development, resulting
in fewer and smaller nephrons.
Precipitating Factors:
Other factors that can increase the risk of chronic kidney disease include:
Signs and symptoms of chronic kidney disease develop over time if kidney damage
progresses slowly. Loss of kidney function can cause a buildup of fluid or body waste or
electrolyte problems. Depending on how severe it is, loss of kidney function can cause:
Nausea and Vomiting: There can be many reasons for nausea and/or
vomiting, such as medicine, being constipated, and toxins building up in your
body because of your failing kidneys.
Loss of appetite: The progressive decline of glomerular filtration rate in
chronic kidney disease patients is associated with a significant reduction in food
intake. Approximately one third of chronic dialysis patients complain of a fair or
poor appetite and this is related directly to poor patient outcomes.
Fatigue and weakness: If the kidneys are not working well, toxins (waste
products) build up in the blood and this can make a patient feel tired and weak
3
University of Saint Louis
Tuguegarao City, Cagayan 3500
and may feel more tired as the CKD progresses. Kidney damage can also lead
to a shortage of red blood cells, causing a patient to be anaemic.
Sleep problems: Excessive daytime sleepiness and sleep disorders, including
sleep apnea syndrome, restless legs syndrome, and periodic limb movement
disorder, occur with increased frequency in patients with end-stage renal
disease (ESRD).
Urinating more or less: When the kidneys filters are damaged, it can cause an
increase in the urge to urinate. On the other hand, renal causes of oliguria arise
as a result of tubular damage. As a result of the tubular damage, the kidney
loses its normal function such as production of urine while excreting the waste
metabolites.
Decreased mental sharpness: Depression, anxiety and other mental health
issues are common among people living with kidney disease.
Muscle cramps: Severe loss of kidney function causes metabolic wastes to
build up to higher levels in the blood. Damage to muscles and nerves can
cause muscle twitches, muscle weakness, cramps, and pain. People may also
feel a pins-and-needles sensation in the arms and legs and may lose sensation
in certain areas of the body.
Swelling of feet and ankles: Damage to the tiny filtering nephrons can result
in what's called nephrotic syndrome. Declining levels of the protein albumin in
the blood and increasing levels in the urine can cause fluid to build up and
result in edema, most commonly around the ankles and feet.
Dry, itchy skin: When phosphorus levels get too high, it can cause the skin to
be dry and irritated. In addition, kidney disease can lead to changes in the
sweat glands, causing the skin to dry out.
High blood pressure (hypertension) that's difficult to control: Diseased
kidneys are less able to help regulate blood pressure. As a result, blood
pressure increases.
Shortness of breath: There can be many causes: low iron levels, extra fluid in
the lungs, build-up of acid in the blood or being anxious.
Chest pain: If the lining that covers the heart (pericardium) becomes inflamed,
the patient may experience chest pain
Signs and symptoms of kidney disease are often nonspecific. This means they can also be
caused by other illnesses. Because the kidneys are able to make up for lost function, the
patient might not develop signs and symptoms until irreversible damage has occurred.
COMPLICATIONS
Chronic kidney disease can affect almost every part of the body. Potential complications
include:
4
University of Saint Louis
Tuguegarao City, Cagayan 3500
Fluid retention, which could lead to swelling in the arms and legs, high blood
pressure, or fluid in the lungs (pulmonary edema)
A sudden rise in potassium levels in the blood (hyperkalemia), which could
impair the heart's function and can be life-threatening
Anemia
Heart disease
Weak bones and an increased risk of bone fractures
Decreased sex drive, erectile dysfunction or reduced fertility
Damage to the central nervous system, which can cause difficulty
concentrating, personality changes or seizures
Decreased immune response, which makes a patient more vulnerable to
infection
Pericarditis, an inflammation of the saclike membrane that envelops the heart
(pericardium)
Pregnancy complications that carry risks for the mother and the developing
fetus
Irreversible damage to the kidneys (end-stage kidney disease), eventually
requiring either dialysis or a kidney transplant for survival
STAGES
CKD often progresses over time and has 5 stages depending on how well the
kidneys are currently able to filter the blood. The filtration rate (GFR) indicates how
well the kidneys are working.
Glomerular filtration rate (GFR) will be calculated using a combination of inputs.
These include age, gender and race, as well as blood’s level of creatinine – a waste
product. If the glomerular filtration rate (GFR) number is low, the kidneys are not
working as well as they should be.
5
University of Saint Louis
Tuguegarao City, Cagayan 3500
Below are the 5 stages of chronic kidney disease (CKD) and their associated glomerular
filtration rates (GFRs).
In the early stages (Stages 1–3), the kidneys are still able to filter waste from the blood. In
the later stages (Stages 4–5), the kidneys must work harder to filter blood and may stop
working altogether.
6
University of Saint Louis
Tuguegarao City, Cagayan 3500
What this means: Like in stage 1, the will likely not notice symptoms of chronic kidney
disease (CKD), but will need to regularly visit a clinician in order to have the GFR monitored
and manage any health problems that may affect kidney functioning.
What this means: The patient may still not notice symptoms of chronic kidney disease (CKD)
but will need a clinician to test regularly for complications and should discuss treatment
options with them to prepare for the case that kidney failure develops.
What this means: The patient may notice symptoms of chronic kidney disease (CKD and
should either be in treatment for chronic kidney disease (CKD) or have discussed treatment
options with a clinician to prepare for the event that kidney failure develops.
What this means: The patient will likely notice symptoms of chronic kidney disease (CKD)
and will need to move forward with the treatment that the clinician have decided is right for
the patient.
Remember that every chronic kidney disease (CKD) patient is unique. Not only glomerular
filtration rate (GFR), but also age, physical condition, medical history and lifestyle will factor
into the clinician’s treatment recommendation. The treatment choice should always be a joint
decision between the patient and the clinician.
There's no cure for chronic kidney disease (CKD), but treatment can help relieve the
symptoms and stop it from getting worse.
7
University of Saint Louis
Tuguegarao City, Cagayan 3500
The treatment will depend on the stage of CKD but the main treatments are:
The following lifestyle measures are usually recommended for people with kidney disease:
Stop smoking
Eat a healthy, balanced diet
Restrict salt intake to less than 6g a day – that's around 1 teaspoon
Do regular exercise – aim to do at least 150 minutes a week
Manage alcohol intake: Drink no more than the recommended limit of 14 units of
alcohol a week
Lose weight if overweight or obese
Avoid over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs), such
as ibuprofen, except when advised to by a medical professional – these medicines
can harm the kidneys if the patient has kidney disease
2. Medicine – to control associated problems, such as high blood pressure and high
cholesterol
There's no medicine specifically for CKD, but medicine can help control many of the
problems that cause the condition and the complications that can happen as a result
of it.
The patient may need to take medicine to treat or prevent the different problems
caused by CKD.
For a small proportion of people with CKD, the kidneys will eventually stop working.
This usually happens gradually, so there should be time to plan the next stage of
treatment.
One of the options when CKD reaches this stage is dialysis. This is a method of
removing waste products and excess fluid from the blood.
An alternative to dialysis for people with severely reduced kidney function is a kidney
transplant. This is often the most effective treatment for advanced kidney disease,
but it involves major surgery and taking medicines (immunosuppressants) for the rest
of the patient’s life to stop the body from attacking the donor organ.
A person can live with one kidney, which means donor kidneys can come from living
or recently deceased donors. But there's still a shortage of donors, and the patient
could wait months or years for a transplant and may need to have dialysis while
waiting for a transplant.
Survival rates for kidney transplants are very good. About 90% of transplants still
function after 5 years and many work usefully after 10 years or more.
6. High cholesterol
People with CKD have a higher risk of cardiovascular disease, including heart
attack and stroke. This is because some of the causes of kidney disease are the
same as those for cardiovascular disease, including high blood pressure and high
cholesterol.
The patient may be prescribed medicines called statins to reduce the risk of
developing cardiovascular disease. Examples include atorvastatin and simvastatin.
Side effects of statins can include:
headaches
feeling sick
constipation or diarrhoea
muscle and joint pain
Find out more about how high cholesterol is treated.
People with hyperkalaemia that does not get better (called persistent CKD) who also
have CKD stage 3b to 5, or heart failure, should only take sodium zirconium
cyclosilicate if they:
o have a serum potassium level of at least 6.0 mmol/litre and
o are not also taking a certain amount of renin-angiotensin-aldosterone
system (RAAS) inhibitor because of hyperkalaemia
o are not on dialysis
The patient should stop taking sodium zirconium cyclosilicate if RAAS inhibitors are no
longer suitable
8. Water retention
The patient may get swelling in your ankles, feet and hands if he has kidney disease.
This is because the kidneys are not as effective at removing fluid from the blood,
causing it to build up in body tissues (oedema).
The patient may be advised to reduce daily salt and fluid intake, including fluids in
food such as soups and yoghurts, to help reduce the swelling.
In some cases, the patient may also be given diuretics (tablets to help the patient pee
more), such as furosemide.
Side effects of diuretics can include dehydration and reduced levels of sodium and
potassium in the blood.
9. Anaemia
Many people with advanced-stage CKD develop anaemia, which is a lack of red blood cells.
Symptoms of anaemia include:
tiredness
lack of energy
shortness of breath
a pounding, fluttering or irregular heartbeat (palpitations)
If the patient has anaemia, injections of a medicine called erythropoietin may be given. This
is a hormone that helps the body produce more red blood cells. If the patient has an iron
deficiency as well, iron supplements may also be recommended.
If the patient has anaemia but do not have iron deficiency, a medicine called Roxadustat
may be given. This medicine helps the body to produce more red blood cells and comes as
tablets.
If the kidneys are severely damaged, it can lead to a build-up of phosphate inthe
body because the kidneys cannot get rid of it.
Along with calcium, phosphate is important for maintaining healthy bones. But if the
phosphate level rises too much, it can upset the balance of calcium in the body
and lead to thinning of the bones.
The patient may be advised to limit the amount food which are high in phosphate,
such as red meat, dairy products, eggs and fish. If this does not lower phosphate
level enough, the patient may be given medicines called phosphate binders.
Commonly used medicines include calcium acetate and calcium carbonate.
Some people with CKD also have low levels of vitamin D, which is necessary for
healthy bones. If vitamin D is low, a supplement called colecalciferol or ergocalciferol
may be given to boost vitamin D level.
11. Glomerulonephritis
Kidney disease can be caused by inflammation of the filters inside the kidneys,
known as glomerulonephritis. In some cases this happens as a result of the immune
system mistakenly attacking the kidneys.
If a kidney biopsy finds this is the cause of kidney problems, medicine to reduce the
activity of the immune system may be prescribed, such as a steroid or a medicine
called cyclophosphamide.
are unlikely to benefit from or have a good quality of life with treatment
do not want to go through the inconvenience of treatment with dialysis
are advised against dialysis because they have other serious illnesses, and the
negative aspects of treatment outweigh any likely benefits
have been on dialysis, but have decided to stop this treatment
are being treated with dialysis, but have another serious illness, such as severe heart
disease or stroke, that will shorten their life
11
University of Saint Louis
Tuguegarao City, Cagayan 3500
The health care provider will use a blood test to check kidney function. The results of
the test mean the following:
a GFR of 60 or more is in the normal range. Ask your health care provider when
your GFR should be checked again.
a GFR of less than 60 may mean you have kidney disease. Talk with your health
care provider about how to keep your kidney health at this level.
a GFR of 15 or less is called kidney failure. Most people below this level need
dialysis or a kidney transplant. Talk with your health care provider about your
treatment options.
NURSING RESPONSIBILITIES
12
University of Saint Louis
Tuguegarao City, Cagayan 3500
1. Blood Collection:
Perform the blood draw using aseptic technique and following established
protocols.
Ensure the patient is comfortable and relaxed during the procedure.
Monitor the patient for any signs of discomfort or adverse reactions.
2. Labeling and Handling:
Label the blood samples accurately with the patient's information and the date
and time of collection.
Ensure proper handling and transportation of the samples to the laboratory.
1. Post-Test Monitoring:
Monitor the patient for any immediate post-procedure complications such as
bleeding, hematoma formation, or lightheadedness.
Provide appropriate care or interventions as needed.
2. Comfort and Support:
Offer reassurance and comfort to the patient if they experienced discomfort
during the blood draw.
Address any concerns or questions the patient may have about the test
results.
3. Documentation:
Document the blood test procedure, including details of the blood draw,
patient's response, and any complications.
Record the time of sample collection and send the samples to the laboratory
for analysis promptly.
4. Follow-Up:
13
University of Saint Louis
Tuguegarao City, Cagayan 3500
Collaborate with the healthcare provider to review and interpret the test
results.
Initiate any necessary interventions or medication adjustments based on the
results.
Educate the patient about the significance of the results and any
recommended changes in their treatment or lifestyle.
5. Communication:
Communicate the test results to the patient, ensuring they understand the
implications and any required actions.
Coordinate follow-up appointments or consultations with the healthcare team
as needed.
If a patient is at risk for kidney disease, the healthcare provider may check urine for
albumin.
Albumin is a protein found in the blood. A healthy kidney doesn’t let albumin pass
into the urine. A damaged kidney lets some albumin pass into the urine. The less
albumin in the urine, the better. Having albumin in the urine is called albuminuria.
A health care provider can check for albumin in the urine in two ways:
Dipstick test for albumin. A provider uses a urine sample to look for albumin in the
urine. The patient collects the urine sample in a container in a health care provider’s
office or lab. For the test, a provider places a strip of chemically treated paper, called
a dipstick, into the urine. The dipstick changes color if albumin is present in the urine.
Urine albumin-to-creatinine ratio (UACR). This test measures and compares the
amount of albumin with the amount of creatinine in eth urine sample. Providers use
the UACR to estimate how much albumin would pass into the urine over 24 hours. A
urine albumin result of
14
University of Saint Louis
Tuguegarao City, Cagayan 3500
If the patient has albumin in the urine, the healthcare provider may want him to repeat the
urine test one or two more times to confirm the results. And if he has kidney disease,
measuring the albumin in the urine helps the provider know which treatment is best. A urine
albumin level that stays the same or goes down may mean that treatments are working.
NURSING RESPONSIBILITIES:
1. Urine Collection:
Instruct the patient on the proper technique for collecting a clean-catch or
midstream urine sample, if applicable.
Provide the necessary materials for urine collection, such as a sterile
container.
Ensure the patient collects the sample correctly and labels it with their name,
date, and time.
2. Specimen Handling:
Properly label the urine sample container with the patient's information.
Ensure the urine sample is stored appropriately, following any specific
storage requirements.
1. Post-Test Monitoring:
Observe the patient for any immediate post-procedure complications or
discomfort.
15
University of Saint Louis
Tuguegarao City, Cagayan 3500
Other tests:
Sometimes other tests are also used to assess the level of damage to the kidneys.
These may include:
o to see what the kidneys look like and check whether there are any blockages
An ultrasound scan
NURSING RESPONSIBILITIES:
3. Informed Consent:
Confirm that the patient understands the procedure and its potential risks and
benefits.
Obtain informed consent from the patient if required by hospital policy or local
regulations.
1. Post-Test Monitoring:
Observe the patient for any immediate post-procedure complications or
discomfort.
Assess the patient for any signs of an adverse reaction to ultrasound contrast
agents if they were used.
2. Documentation:
Document the ultrasound procedure, including patient positioning, any
complications or reactions, and the date and time of the scan.
Ensure accurate labeling of the images and any documentation required by
the healthcare facility.
3. Patient Care:
Assist the patient in returning to their regular clothing if necessary.
Provide any additional care or comfort measures as needed.
4. Follow-Up:
Collaborate with the healthcare provider to review the ultrasound findings and
their implications for the patient's care.
Educate the patient about the results and any recommended follow-up
actions or treatments.
5. Communication:
Communicate the results to the patient and answer any questions they may
have.
Ensure timely reporting of the ultrasound findings to the healthcare team for
further management.
MRI scan
NURSING RESPONSIBILITIES:
1. Post-Test Monitoring:
Observe the patient for any immediate post-procedure complications or
reactions, such as dizziness or allergic reactions.
Assess the patient's vital signs and general well-being.
2. Hydration and Kidney Protection:
18
University of Saint Louis
Tuguegarao City, Cagayan 3500
Encourage the patient to continue hydrating after the scan, as this can help
flush out any contrast dye and protect their kidneys.
Be vigilant for any signs of contrast-induced nephropathy, such as changes in
urine output or kidney function, and report them to the healthcare team.
3. Documentation:
Document the MRI procedure, including patient positioning, any
complications, and the date and time of the scan.
Ensure accurate labeling and storage of MRI images and any required
documentation for the healthcare facility.
4. Patient Care:
Assist the patient in getting dressed and provide any necessary post-scan
care or comfort measures.
5. Follow-Up:
Collaborate with the healthcare provider to review and interpret the MRI
findings.
Educate the patient about the results and any recommended follow-up
actions or treatments.
6. Communication:
Communicate the MRI results to the patient and address any questions or
concerns they may have.
Ensure timely reporting of the MRI findings to the healthcare team for further
management.
CT scan
NURSING RESPONSIBILITIES:
1. Post-Test Monitoring:
Observe the patient for any immediate post-procedure complications or
reactions, such as allergic reactions or delayed nausea.
Assess the patient's vital signs and general well-being.
2. Hydration and Kidney Protection:
Encourage the patient to continue hydrating after the scan to help flush out
any contrast dye and protect their kidneys.
Be vigilant for any signs of contrast-induced nephropathy, such as changes in
urine output or kidney function, and report them to the healthcare team.
3. Documentation:
Document the CT scan procedure, including patient positioning, any
complications, and the date and time of the scan.
Ensure accurate labeling and storage of CT images and any required
documentation for the healthcare facility.
4. Patient Care:
Assist the patient in getting dressed and provide any necessary post-scan
care or comfort measures.
5. Follow-Up:
Collaborate with the healthcare provider to review and interpret the CT scan
findings.
Educate the patient about the results and any recommended follow-up
actions or treatments.
6. Communication:
Communicate the CT scan results to the patient and address any questions
or concerns they may have.
20
University of Saint Louis
Tuguegarao City, Cagayan 3500
Ensure timely reporting of the CT findings to the healthcare team for further
management.
A kidney biopsy – a small sample of kidney tissue is removed and the cells are
examined under a microscope for signs of damage
NURSING RESPONSIBILITIES:
21
University of Saint Louis
Tuguegarao City, Cagayan 3500
Continuously monitor the patient's vital signs, including blood pressure, heart
rate, and oxygen saturation.
Document the procedure, including patient positioning, the number of biopsy
samples obtained, and any complications or patient reactions.
1. Post-Procedure Monitoring:
Observe the patient closely for several hours after the biopsy to monitor for
any immediate complications such as bleeding, hematoma formation, or signs
of infection.
Assess the patient's vital signs at regular intervals and record them.
2. Pain Management:
Manage post-biopsy pain by administering pain medications as ordered by
the healthcare provider.
Ensure the patient is comfortable and provide pain relief as needed.
3. Post-Biopsy Care:
Encourage the patient to maintain strict bed rest for a specified period as
determined by the healthcare provider.
Monitor the biopsy site for any signs of bleeding, infection, or other
complications.
Administer antibiotics if prescribed to prevent infection.
4. Hydration and Kidney Function:
Promote hydration to help flush out contrast dye and minimize the risk of
contrast-induced nephropathy.
Monitor kidney function by assessing urine output and laboratory results.
5. Communication:
Report any concerns, complications, or changes in the patient's condition to
the healthcare provider promptly.
Communicate the biopsy results to the patient and address any questions or
concerns they may have.
6. Education and Discharge Planning:
Educate the patient about post-biopsy care instructions, including limitations
on physical activity, signs of complications to watch for, and follow-up
appointments.
Coordinate discharge planning and ensure the patient has appropriate
transportation home.
stage 2 (G2) – a slightly reduced eGFR of 60 to 89ml/min, with other signs of kidney
damage
stage 3a (G3a) – an eGFR of 45 to 59ml/min
stage 3b (G3b) – an eGFR of 30 to 44ml/min
stage 4 (G4) – an eGFR of 15 to 29ml/min
stage 5 (G5) – an eGFR below 15ml/min, meaning the kidneys have lost almost all of
their function
For both eGFR and ACR, a higher stage indicates more severe kidney disease.
STATISTICS
LOCAL STATISTICS
23
University of Saint Louis
Tuguegarao City, Cagayan 3500
NATIONAL STATISTICS
Description: There were 24,489 deaths in the year 2021 which is considered the highest
number of cases in the Philippines with the rate of 2,428,327 from within the years 2017 and
2021.
INTERNATIONAL STATISTICS
Description: There were 4 million deaths in the year 2021 which is considered the highest
number of cases globally with the rate of 933 milion from within the years 2017 and 2021.
24
University of Saint Louis
Tuguegarao City, Cagayan 3500
PATIENT’S PROFILE
NAME: D.B. S
SEX: Male
AGE: 42 years 5 months
BIRTHDATE: March 26, 1981
ADDRESS: City of Tabuk
NATIONALITY: Filipino
DIALECT: Kalinga, Ilocano, Tagalog
RELIGION: Free Believers in Christ
OCCUPATION: Farming
CIVIL STATUS: Married
DATE OF ADMISSION: September 12, 2023
TIME OF ADMISSION: 3:41 PM
CHIEF COMPLAINT: Generalized muscle cramps
ADMITTING DIAGNOSIS: To consider Electrolyte Imbalance Chronic Kidney Disease
secondary to Diabetes Mellitus
FINAL DIAGNOSIS: ---
ATTENDING PHYSICIAN: Dr. Edmund C. Bautista, M. D.
SURGICAL PROCEDURE: Internal Jugular Insertion
DATE HANDLED: September 26, 2023
25
University of Saint Louis
Tuguegarao City, Cagayan 3500
FAMILY HISTORY
26
University of Saint Louis
Tuguegarao City, Cagayan 3500
SOCIAL HISTORY
The SO stated that patient D.B. S is a high school graduate. He is an Ilocano,
Kalinga and Tagalog speaker who works on the farm every day of the week at an irregular
27
University of Saint Louis
Tuguegarao City, Cagayan 3500
time. The SO stated that the patient spends most of his time working and only goes back
home at night to rest and spend quality time with his wife and three children. In terms of
budget and expenses, patient D. B. S is able to provide for their basic needs and she
described him as a very thrifty man.
ENVIRONMENTAL HISTORY
The significant other stated that the patient’s house is a small, concrete bungalow-
style house with one bedroom. She said that it is fairly clean and well-lit and added that the
place is safe and conducive environment since she often visits them. According to the SO,
the patient has a nuclear type of family. She added that no one from within the patient’s
family smokes cigarettes and uses e-cigarettes nor drinks any alcoholic beverages. The SO
also added that the patient uses “nganga” (betel nut in English) most of the time and he has
been doing it since his teenage years. Their electricity is being provided by Kalinga-Apayao
Electric Cooperative. In terms of water, she stated that they use tap water. They do not have
any other pets besides two dogs but there are many stray animals in their neighborhood.
The area is accessible by riding on a bus en route to their area. Upon arrival, they still have
to ride a pedicab since their house is located at the extremity of their community.
28
University of Saint Louis
Tuguegarao City, Cagayan 3500
32
University of Saint Louis
Tuguegarao City, Cagayan 3500
PHYSICAL ASSESSMENT
Date of Assessment: September 26, 2023 at 10 AM
General Appearance: Received patient on a Semi-Fowler’s Position asleep with ongoing IV
fluid of Normal Saline 1 Liter x KVO at 500 mL on left arm, hooked to Oxygen Support, with
Nasogastric and Internal Jugular inserted on the right side of the neck. Upon assessment,
the patient is weak and lethargic.
Upon Assessment Vital Signs:
Blood Pressure: 130/90 mmHg Height: ---
Pulse Rate: 93 bpm Weight: ---
Respiratory rate: 16 cpm BMI: ---
Temperature: 37.0 C
Oxygen Saturation: 96%
Pain Scale: ---
33
University of Saint Louis
Tuguegarao City, Cagayan 3500
Texture Inspection Smooth, Firm, and Silky The hair is smooth, Normal
and firm and silky.
Palpation
Parasite Inspection No infestation No infestation Normal
and
Palpation
SCALP
Symmetry Inspection Symmetrical, appropriate Symmetrical, Normal
with age, gender, and appropriate with age,
body structure gender, and body
structure
Appearance Inspection No seborrheic dermatitis, No seborrheic Normal
lesions, and dermatitis, lesions,
inflammations and inflammations
Head
Shape and Inspection Normocephalic and Normocephalic and Normal
Symmetry Symmetric Symmetric
Consistency Inspection Hard and smooth; Hard and smooth; Normal
without nodules, masses, without nodules,
and depressions masses, and
depressions
Facial Features Inspection No dysmorphic features No dysmorphic Normal
and no presence of features and no
lesions and edema presence of lesions
and edema
Nails
Color of Nail Inspection Pinkish in color Presence of pallor Not normal
Bed and slightly yellow in due to the
color accumulation
of nitrogen
waste in the
bloodstream
Curvature Inspection Convex Convex Normal
Tissue Palpation Epidermis is intact Epidermis is intact Normal
surrounding
nail
Texture Palpation Smooth The nails are brittle Not normal
and ridged due to a low
level of keratin
Capillary Refill Palpation Pink tone returns Pink tone returns Normal
Time immediately when immediately when
pressure is released (< 2 pressure is released
seconds) (< 2 seconds)
Face
Symmetry Inspection Proportionate and Proportionate and Normal
Symmetric Symmetric
Facial Inspection Movements are equal The patient Not normal due
Movement bilaterally experiences difficulty to imbalanced
in making facial fluid and
34
University of Saint Louis
Tuguegarao City, Cagayan 3500
movements electrolytes,
diminished
muscle control,
weakness and
diminished
physical
activities
Color Inspection Same as body color Same as body color Normal
Eyebrows
Distribution Inspection Hair distributed evenly Brow hairs are Normal
evenly distributed
Quality of Inspection Equal movement The patient Not normal due
movement experiences difficulty to imbalanced
in making facial fluid and
movements electrolytes,
diminished
muscle control,
weakness and
diminished
physical
activities
Alignment Inspection Symmetrically Symmetrically Normal
aligned aligned
Eyelashes
Evenness Inspection Distributed equally Lash hairs are Normal
equally distributed
Direction of curl Inspection Curled outwards Lashes are slightly Normal
Slightly curled outwards
Appearance Inspection Combed, moisturized, Presence of dried up Not normal due
nourished and hard rheum to decreased
self-care
abilities due to
hospitalization
Eyes
Position, Size, Inspection Symmetric Eyes are symmetrical Normal
And Shape
Movement Inspection Symmetrical in The patient Not normal due
movement experiences difficulty to diminished
in making facial muscle control,
movements weakness and
diminished
physical
activities
Eyelids Inspection Without swelling, Presence of oil build- Not normal due
discharge and lesions up and dried up, hard to decreased
rheum self-care
35
University of Saint Louis
Tuguegarao City, Cagayan 3500
abilities due to
hospitalization
Conjunctiva Inspection Pinkish; free of Presence and Not normal due
discharge, lesions, accumulation of eye to decreased
redness and lacerations discharge self-care
abilities due to
hospitalization
Sclera Inspection White; free of discharge, Presence of redness Not normal due
lesions, redness and in the sclera of the to impaired
lacerations eyes blinking and
tear formation,
leading to dry
eyes
Pupils Inspection Color varies with race; The patient’s pupils Normal
PERRLA are black, equal,
round and reactive to
light and
accommodation
Iris Inspection Round, flat and evenly Round, flat and Normal
colored evenly colored
Pupils
Color Inspection Black in color (according The patient’s pupils Normal
to race, no cloudiness). are black in color (no
cloudiness)
Shape Inspection Round and has smooth Round and has Normal
border smooth border
Symmetry of Inspection Equal in size Equal in size Normal
size
Perrla
Accommodation Inspection Pupils constrict looking Pupils constrict Normal
at near object; dilate looking at near
looking at far object. object; dilate looking
at far object.
Reaction to light Inspection Pupil constricts Pupil constricts Normal
when illuminated when illuminated
(Direct (Direct
response). response).
responsive
Extra ocular Inspection Coordinated and has *NOTE: I was not *NOTE: I was
movement unison movement of both able to perform this not able to
eyes with parallel assessment because perform this
alignment. the patient is weak assessment
and minimally because the
responsive patient is weak
and minimally
responsive
Ears
Position Inspection Symmetric The ears are Normal
symmetrical
Size and Shape Inspection Symmetric on both sides Symmetric on both Normal
sides
Color Inspection Consistent with facial The ears are Normal
color consistent with facial
color
Texture Palpation Smooth without lesions, Smooth without Normal
lumps or nodules lesions, lumps or
nodules
Discharge Inspection No discharges No discharges Normal
Hearing Acuity Inspection Responds to sound The patient does not Not normal due
respond to sound to weakness
and diminished
(The significant other physical
confirms that the activities
patient does not have
problems with
hearing)
Mouth
Lip Consistency Inspection Smooth and moist The lips are smooth Normal
without lesions and and moist without
swelling lesions and swelling
Lip Color Inspection Uniform pink color Uniform pink Normal
color
Soft, moist and the
texture is smooth Soft, moist and the
texture is smooth
Symmetrical contour
Symmetrical contour
Teeth Inspection White, no tartars, no Teeth are white, with Not normal
dental carries, complete presence of tartars, due to
set of teeth no dental carries decreased self-
care abilities
during
hospitalization
Gums Inspection Pink and Moist Gums Pink and moist gumsNormal
37
University of Saint Louis
Tuguegarao City, Cagayan 3500
Buccal Mucosa Inspection Pink and moist without *NOTE: I was not *NOTE: I was
and lesions able to perform this not able to
Palpation assessment because perform this
the patient is weak assessment
and minimally because the
responsive patient is weak
and minimally
responsive
Nose
Position and Inspection Midline in face; Midline in face; Normal
Size Symmetric Symmetric
Configuration of Inspection With nose bridge; With nose bridge; Normal
The Nose located at the midline located at the
Bridge midline
Color Inspection Same as the rest of the Same as the rest of Normal
body the body
Tenderness, Palpation No tenderness or No tenderness or Normal
Masses, And masses masses
Lesions
Patency Inspection Air moves freely as the Air moves freely as Normal
and patient breaths through the patient breaths
Palpation the nares. through the nares.
38
University of Saint Louis
Tuguegarao City, Cagayan 3500
Nasal Flaring Inspection No nasal flaring There is presence of Not normal due
nasal flaring to pooling of
liquid in the
tissues
because of
prolonged bed
rest
Neck
Mobility Inspection Coordinated, smooth The patient has Not normal
movements with no muscle twitches in due to
discomfort association the area imbalances in
fluid and
electrolytes,
diminished
muscle control,
weakness and
diminished
physical
activities
Position and Inspection Head at center Head at center Normal
Characteristics
Muscles are symmetrical Muscles are
in size symmetrical in size
Thorax
Shape Inspection Smooth, Rounded and Smooth, Rounded Normal
Symmetric and Symmetric
Respiratory Inspection Respirations should be Respirations should Normal
Effort unlabored and unregular; be unlabored and
RR = 18-20 cpm unregular; RR = 18-
20 cpm
Tenderness and Palpation No tenderness or mass No tenderness or Normal
Masses noted mass noted
Breath Sounds Auscultation There is no presence of There is no Normal
wheezing, sighing, presence of
panting, deep inhalations wheezing, sighing,
and exhalations. panting, deep
inhalations and
exhalations.
Heart
Apical Pulse Auscultation Regular and Rapid; 60- Regular and Rapid; Normal
100 bpm 60-100 bpm
Heart Sounds Auscultation Louder, higher Louder, higher Normal
pitched, and pitched, and
of shorter duration; of shorter duration;
innocent murmurs are innocent murmurs
normal are normal
Abdomen
39
University of Saint Louis
Tuguegarao City, Cagayan 3500
40
University of Saint Louis
Tuguegarao City, Cagayan 3500
41
University of Saint Louis
Tuguegarao City, Cagayan 3500
1. Blood flows into the kidneys through a large blood vessel called the renal artery.
2. Tiny blood vessels in the kidney filter the blood.
3. The filtered blood returns to the bloodstream through a large blood vessel called the
renal vein.
4. Pee travels through tubes of muscle called ureters to the bladder.
5. The bladder stores urine until it is released through urination.
42
University of Saint Louis
Tuguegarao City, Cagayan 3500
An adrenal gland sits on top of each kidney. It produces hormones, including cortisol, which
helps the body respond to stress.
Controlling metabolism.
Reducing inflammation.
Regulating blood pressure.
Increasing blood sugar levels.
● Glomeruli: Glomeruli are groups of tiny blood vessels that perform the first stage of
filtering blood. They then pass filtered substances to the renal tubules. The name for this
process is glomerular filtration.
● Rena tubules: these tiny tubules reabsorb and return water, nutrients and minerals the
body needs (including sodium and potassium). The tubules remove waste, including
excess acid and fluids through a process called diffusion. The body sends the remaining
waste through the kidneys’ collecting chambers. Eventually, it leaves the body as urine.
ANATOMY
Where are the kidneys located?
The kidneys sit just below the ribcage and behind the belly. Typically, one kidney sits
on either side of the spine. The kidneys reside between the intestines and diaphragm. A
ureter connects each kidney to the bladder.
What are the parts of the kidney?
The kidneys are highly complex organs with many parts. The main parts of the
kidney anatomy include:
Kidney capsule (renal capsule): The renal capsule consists of three layers of
connective tissue or fat that cover your kidneys. It protects your kidneys from injury,
increases their stability and connects your kidneys to surrounding tissues.
43
University of Saint Louis
Tuguegarao City, Cagayan 3500
Renal artery: The renal artery is a large blood vessel that controls blood flow into
your kidneys. For most people at rest, the renal kidneys pump a little over 5 cups (1.2
liters) of blood to your kidneys each minute.
Renal cortex: The outer layer of your kidney, where the nephrons (blood-filtering
units) begin. The renal cortex also creates the hormone erythropoietin (EPO), which
helps make red blood cells in your bone marrow.
Renal medulla: The renal medulla is the inner part of your kidney. It contains most of
the nephrons with their glomeruli and renal tubules. The renal tubules carry urine to
the renal pelvis.
Renal papilla: These pyramid-shaped structures transfer urine to the ureters.
Dehydration and certain medications — especially nonsteroidal anti-inflammatory
drugs (NSAIDs) — may damage your renal papilla.
Renal pelvis: This funnel-shaped structure collects urine and passes it down two
ureters. Urine travels from the ureters to the bladder, where it’s stored.
Renal vein: This vein is the main blood vessel that carries filtered blood out of your
kidneys and back to your heart. Each of your kidneys has a renal vein.
Chronic kidney disease: CKD may lessen kidney function. Diabetes or high blood
pressure usually causes CKD.
Kidney cancer: Renal cell carcinoma is the most common type of kidney cancer.
Kidney failure (renal failure): It may be acute (worsen suddenly) or chronic (a
permanent lessening of how well your kidneys work). ESRD is a complete loss of
44
University of Saint Louis
Tuguegarao City, Cagayan 3500
kidney function. It requires dialysis (treatment to filter the blood in place of the
kidneys).
Kidney infection (pyelonephritis): A kidney infection can occur if bacteria enter the
kidneys by traveling up the ureters. These infections cause sudden symptoms.
Healthcare providers treat them with antibiotics.
Kidney stones: This cause crystals to form in your urine and may block urine flow.
Sometimes these stones pass on their own. In other cases, healthcare providers can
offer treatment to break them up or remove them.
Kidney (renal) cysts: Fluid-filled sacs called kidney cysts grow on the kidneys.
These cysts can cause kidney damage. Healthcare providers can remove them
Polycystic kidney disease: This causes cysts to form on the kidneys. PKD is a
genetic condition. It may lead to high blood pressure and kidney failure. People with
PKD need regular medical monitoring.
Countless other disorders can affect the kidneys. Some of these conditions include:
Acidosis: Excess acid accumulates in your kidneys, which may cause many health
problems. It can be life-threatening.
Acute or interstitial nephritis: The kidneys become inflamed, sometimes after
exposure to certain antibiotics, which may lead to kidney failure.
Azotemia: Nitrogen waste builds up in the kidneys. Without treatment, azotemia may
be fatal.
Caliectasis: Excess fluid causes the calyces (where urine collection begins) to swell.
Without treatment, caliectasis may result in kidney failure.
Diabetes-related nephropathy or hypertensive nephropathy: Unmanaged
diabetes or chronically high blood pressure causes kidney damage.
Glomerular diseases: This may inflammation or damage to the glomeruli.
Glomerular diseases may cause kidney failure.
Minimal change disease and nephrotic syndrome: This may cause the kidneys to
release the excess protein the urine.
Papillary necrosis: Chunks of kidney tissue die in the medulla and papilla. The
tissue can break off and clog the kidneys, leading to kidney failure.
Proteinuria: This means that a patient has high levels of protein in the kidneys. It
can be a sign of kidney damage.
Pyelonephritis: This sudden kidney infection causes edema (swelling) in the
kidneys. It can be life-threatening.
Uremia: Toxins that normally leave the body through the urine end up in the
bloodstream. Without treatment, uremia can be fatal.
More frequent urination: Problems filtering waste can cause the patient to urinate
more often.
Puffy eyes or swollen ankles and feet: Reduced kidney function can cause he
body to hold onto protein and sodium, resulting in swelling.
Sleep problems, fatigue and lack of appetite: If toxins build up in the blood, sleep,
appetite and energy levels may be off.
Kidney failure is generally a multi-organ health issue, with a variety of cross effects on
different body systems.
46
University of Saint Louis
Tuguegarao City, Cagayan 3500
Joints
Amyloidosis, a condition in which the protein amyloid is deposited in the joints and tendons,
is caused by kidney failure. Amyloidosis often results in pain, stiffness and fluid buildup in
the joints.
47
University of Saint Louis
Tuguegarao City, Cagayan 3500
admission condition
Inform Dr. Aguinaldo For further monitoring Informed Dr. Aguinaldo
once patient is at the management and once the patient is ward
ward evaluation of the patient's
condition
Vital signs every 4 ● To closely ● Educated patient
hours, intake and
output every shift and assess and the purpose of
record monitor the vital monitoring vital
signs for any signs frequently.
deviation and
abnormal ● Monitored and
findings. documented
Vital signs patient’s VS as
assessment serves ordered.
as an early warning ● Referred abnormal
of a change in
patient condition, deviation from
playing an important normal values to
role in assisting the the physician
healthcare immediately.
professional to ● Monitored intake
prevent adverse
and output as
events.
ordered
To monitor fluid
balance of a patient
Monitoring of intake
help caregivers
ensure that the
patient has proper
intake of fluid and
other nutrients
Monitoring of output
helps determine
whether there is
adequate output of
urine as well as
normal defecation
To assess kidney
function, manage
fluid balance, detect
electrolyte
imbalances,
evaluate medication
effects, adhere to
dietary restrictions,
and assess
treatment efficacy
Relay all laboratories To provide valuable Reviewed
once available information about the laboratory results
patient’s health, Relayed all
including blood counts laboratories once
51
University of Saint Louis
Tuguegarao City, Cagayan 3500
52
University of Saint Louis
Tuguegarao City, Cagayan 3500
prescribed
medication.
Administered the
medication
following the 14
Rights of Drug
Administration.
Monitored for any
adverse effects.
needs further
monitoring.
● For collaboration
and continuation of
care to meet the
needs of the patient
9/13/2023 Secure consent for ● To ensure a better ● Secured consent
At 8:45 AM Internal Jugular
understanding of from the patient’s
insertion and
the surgery and SO for surgical
Hemodialysis treatments that will operation and
be provided. management.
● To obtain ● Verified and
permission for the witnessed the
procedure and signing of consent.
management
Refer to Dr. H. For collaboration and Referred the patient to
Jamombon for Internal continuation of care to Dr. H. Jamombon for
Jugular insertion once meet the needs of the Internal Jugular
with consent patient insertion once with
consent
Intravenous Fluid to
follow: PNSS 500cc + To help maintain ● informed the
100 mEqs sodium the right fluid patient’s SO
chloride x 24 hours balance in the body about the
To maintain details, purpose
catheter patency by and importance
preventing internal of the prescribed
luminal (inner medication
surface) occlusion
to restore or ● administered
maintain normal and
fluid volume and incorporated the
electrolyte balance medication to
when the oral route present
is not possible. intravenous fluid
useful for daily following the 14
maintenance of Rights of Drug
body fluids and Administration.
nutrition, and for
rehydration ● Assessed the
patient's vital
signs before
infusion.
● Verified the
prescription and
ensured the
right IV is given
to the right
patient.
● IVF hooked,
regulated at
desired dose,
and ensured IV-
54
University of Saint Louis
Tuguegarao City, Cagayan 3500
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
HBsAg (Hepatitis B This is because the Referred the
Surface Antigen), Anti patient may be ordered tests to
HCV, Anti_HBS exposed to blood and other members of
other bodily fluids the healthcare team
during treatment and Explained the
kidney impairment procedures and
means that the patient purpose of the
is at more risk of laboratory tests to
infection or disease the significant other
To slow development Prepared the
of liver disease and patient for the
reduce the risk of procedures
HCV-related post- Reviewed values
transplant and reported any
complications abnormal values
Monitored puncture
site (complete blood
count) for oozing or
hematoma
formation
9/14/2023 Metoclopromide 1 To help improve
At 12 noon ampule/IV every 8 gastrointestinal Informed patient
hours round the clock motility and reduce about the details,
nausea and vomiting purpose, and
importance of the
prescribed
medication.
Administered the
medication
following the 14
Rights of Drug
Administration.
Monitored for any
adverse effects.
Intravenous fluid to
follow: PNSS 500cc + To help maintain ● informed the
100 mEqs Sodium the right fluid patient’s SO
Chloride for 24 hours balance in the body about the
To maintain details, purpose
catheter patency by and importance
preventing internal of the prescribed
luminal (inner medication
surface) occlusion
to restore or ● administered
maintain normal and
55
University of Saint Louis
Tuguegarao City, Cagayan 3500
preventing internal
luminal (inner of the prescribed
surface) occlusion medication
to restore or
maintain normal ● administered
fluid volume and and
electrolyte balance incorporated the
when the oral route medication to
is not possible. present
useful for daily intravenous fluid
maintenance of following the 14
body fluids and Rights of Drug
nutrition, and for Administration.
rehydration
● Assessed the
patient's vital
signs before
infusion.
● Verified the
prescription and
ensured the
right IV is given
to the right
patient.
● IVF hooked,
regulated at
desired dose,
and ensured IV-
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
9/16/2023 PNSS 90 cc + 10
At 7:12 AM mEqs Potassium To help maintain ● informed the
Chloride every hour x the right fluid patient’s SO
10 cycles balance in the body about the
To maintain details, purpose
catheter patency by and importance
preventing internal of the prescribed
luminal (inner medication
surface) occlusion
to restore or ● administered
maintain normal and
fluid volume and incorporated the
electrolyte balance medication to
when the oral route present
is not possible. intravenous fluid
useful for daily following the 14
maintenance of Rights of Drug
body fluids and Administration.
nutrition, and for
rehydration ● Assessed the
patient's vital
57
University of Saint Louis
Tuguegarao City, Cagayan 3500
signs before
infusion.
● Verified the
prescription and
ensured the
right IV is given
to the right
patient.
● IVF hooked,
regulated at
desired dose,
and ensured IV-
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
At 12 noon Start Potassium To help maintain
Chloride drip the right fluid ● informed the
balance in the body patient’s SO
about the
details, purpose
and importance
of the prescribed
medication
● administered the
medication
following the 14
Rights of Drug
Administration.
● Assessed the
patient's vital
signs before
infusion.
● Verified the
prescription and
ensured the
right IV is given
to the right
patient.
● IVF hooked,
regulated at
desired dose,
and ensured IV-
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
58
University of Saint Louis
Tuguegarao City, Cagayan 3500
Intravenous Fluid to
follow: PNSS 500cc + To help maintain ● informed the
100 mEqs Sodium the right fluid patient’s SO
Chloride x 24 hours balance in the body about the
To maintain details, purpose
catheter patency by and importance
preventing internal of the prescribed
luminal (inner medication
surface) occlusion
to restore or ● administered
maintain normal and
fluid volume and incorporated the
electrolyte balance medication to
when the oral route present
is not possible. intravenous fluid
useful for daily following the 14
maintenance of Rights of Drug
body fluids and Administration.
nutrition, and for
rehydration ● Assessed the
patient's vital
signs before
infusion.
● Verified the
prescription and
ensured the
right IV is given
to the right
patient.
● IVF hooked,
regulated at
desired dose,
and ensured IV-
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
Secure consent for ● To ensure a better ● Secured consent
Internal Jugular
understanding of from the patient’s
insertion and
the surgery and SO for surgical
Hemodialysis treatments that will operation and
be provided. management.
● To obtain ● Verified and
permission for the witnessed the
procedure and signing of consent.
management
9/16/2023 Paracetamol 300mg IV ● Explained the
● For mild to
At 1:30 PM now then every 6 hours purpose of the
as needed for pain moderate pain medication to
relief and to treat the patient.
conditions such ● Followed the
59
University of Saint Louis
Tuguegarao City, Cagayan 3500
patient.
● IVF hooked,
regulated at
desired dose,
and ensured IV-
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
Sodium, Potassium To determine imbalances in Referred the
tomorrow fluid and electrolytes and ordered tests to
measure how well the other members of
kidneys are performing the healthcare team
their job of filtering waste Explained the
from the blood procedures and
purpose of the
laboratory tests to
the significant other
Prepared the
patient for the
procedures
Reviewed values
and reported any
abnormal values
Monitored puncture
site (complete blood
count) for oozing or
hematoma
formation
Clonazepam 2 mg/tab ●
Explained the
● To manage seizures
hours of sleep purpose of the
or alleviate anxiety medication to
and sleep disorders the patient.
● Followed the
14 rights of
drug
administration.
● Monitored
patient for
presence of
adverse effects
At 2:40 PM May give Diazepam 5 ● Explained the
● To manage anxiety,
mg/IV if still with purpose of the
restlessness seizures or muscle medication to
spasms the patient.
● Followed the
14 rights of
drug
administration.
Monitored patient for
presence of adverse
61
University of Saint Louis
Tuguegarao City, Cagayan 3500
effects
Refer if with To determine appropriate Observed patient for
restlessness measures, treatment and restlessness and
intervention for patient reported for signs that
safety deviate from normal
9/18/2023 For Hemodialysis To filter wastes and Referred the
At 8 AM today (2nd shift) water from the blood, ordered tests to
as the kidneys did other members of
when they were the healthcare team
healthy and fully Explained the
functional. procedures and
Hemodialysis helps purpose of the
control blood pressure procedure to the
and balance important significant other
minerals such as Prepared the
potassium, sodium and patient for the
calcium in the blood. procedures
Reviewed values
and reported any
abnormal values
Monitored puncture
site (complete blood
count) for oozing or
hematoma
formation
Intravenous Fluid to
follow: PNSS 500cc + To help maintain ● informed the
40 mEqs Potassium the right fluid patient’s SO
Chloride x 24 hours balance in the body about the
To maintain details, purpose
catheter patency by and importance
preventing internal of the prescribed
luminal (inner medication
surface) occlusion
to restore or ● administered
maintain normal and
fluid volume and incorporated the
electrolyte balance medication to
when the oral route present
is not possible. intravenous fluid
useful for daily following the 14
maintenance of Rights of Drug
body fluids and Administration.
nutrition, and for
rehydration ● Assessed the
patient's vital
signs before
infusion.
● Verified the
prescription and
ensured the
right IV is given
to the right
patient.
● IVF hooked,
62
University of Saint Louis
Tuguegarao City, Cagayan 3500
regulated at
desired dose,
and ensured IV-
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
At 6:52 PM Please give 1 vial D5050 is a therapeutic
D5050 now agent that functions to ● informed the
relieve or alleviate dialysis- patient’s SO
related muscle cramps about the
(DMCs) details, purpose
and importance
of the prescribed
medication
● administered
and the
medication
following the 14
Rights of Drug
Administration.
● Assessed the
patient's vital
signs before the
administration
● Verified the
prescription and
ensured the
right medication
is given to the
right patient.
● Medication
hooked,
regulated at
desired dose,
and ensured IV-
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
Hook to oxygen To help patients with ● Assessed the
support at 1-2 Liters breathing problems get patient’s vital
per minute via nasal enough oxygen to function signs prior to the
cannula and stay well
procedure
● Verified the
prescription and
ensured the
63
University of Saint Louis
Tuguegarao City, Cagayan 3500
right order is
given to the
right patient
● Oxygen
inhalation
hooked,
regulated at
desired dose,
and ensured
nasal patency
● Continued
monitoring
during and after
the procedure
Refer
● To Inform the ● Referred the
attending patient accordingly
physician for any
deviation unusual
signs and
symptoms that
needs further
monitoring.
● For collaboration
and continuation
of care to meet
the needs of the
patient
8:38 PM D5050 1 vial IV every 6 D5050 is a therapeutic
hours agent that functions to ● informed the
relieve or alleviate dialysis- patient’s SO
related muscle cramps about the
(DMCs) details, purpose
and importance
of the prescribed
medication
● administered
and the
medication
following the 14
Rights of Drug
Administration.
● Assessed the
patient's vital
signs before the
administration
● Verified the
prescription and
ensured the
64
University of Saint Louis
Tuguegarao City, Cagayan 3500
right medication
is given to the
right patient.
● Medication
hooked,
regulated at
desired dose,
and ensured IV-
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
9/19/2023 Give Paracetamol 300 For mild to moderate pain
At 7:05 AM mg IV every 4 hours as relief and to treat conditions Informed patient
needed such as headache and about the details,
muscle aches purpose, and
importance of the
prescribed
medication.
Administered the
medication
following the 14
Rights of Drug
Administration.
Monitored for any
adverse effects.
65
University of Saint Louis
Tuguegarao City, Cagayan 3500
● administered
and the
medication
following the 14
Rights of Drug
Administration.
● Assessed the
patient's vital
signs before the
administration
● Verified the
prescription and
ensured the
right medication
is given to the
right patient.
● Medication
hooked,
regulated at
desired dose,
and ensured IV-
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
Intravenous fluid to
follow: PNSS 500 cc + To help maintain ● informed the
50 mEqs Sodium the right fluid patient’s SO
Chloride + 20 mEqs balance in the body about the
Potassium Chloride x To maintain details, purpose
catheter patency by and importance
24 hours of the prescribed
preventing internal
luminal (inner medication
surface) occlusion
to restore or ● administered
maintain normal and
fluid volume and incorporated the
electrolyte balance medication to
when the oral route present
is not possible. intravenous fluid
useful for daily following the 14
maintenance of Rights of Drug
body fluids and Administration.
nutrition, and for
● Assessed the
66
University of Saint Louis
Tuguegarao City, Cagayan 3500
rehydration
patient's vital
signs before
infusion.
● Verified the
prescription and
ensured the
right IV is given
to the right
patient.
● IVF hooked,
regulated at
desired dose,
and ensured IV-
line patency.
● Continued
monitoring
during and after
the infusion
especially for
adverse effects.
Soft Diet Soft diet serves as a Monitored
transition from liquids to dietary intake
a regular diet for Instructed
individuals who are patient’s SO to
recovering from surgery follow a soft diet.
or a long illness Ensured
patient’s
adherence to
prescribed
dietary
restrictions
9:15 PM For Nasogastric tube Nasogastric tubes are Referred the
insertion typically used ordered procedure
for decompression of the to other members of
stomach in the setting of the healthcare team
Explained the
intestinal obstruction or
purpose of the
ileus, but can also be procedure tests to
used to administer the significant other
nutrition or medication to Prepared the
patients who are unable patient for the
to tolerate oral intake. procedure
Monitored the
patient closely
during and after the
procedure
1600 kal in 6 equally To ensure that the Monitored
divided feeding patient is able to receive dietary intake
complete nutrition Instructed
despite being restricted patient’s SO to
and hospitalized follow the
ordered diet.
Ensured
patient’s
67
University of Saint Louis
Tuguegarao City, Cagayan 3500
adherence to
prescribed
dietary
restrictions
Refer
● To Inform the ● Referred the
attending patient
physician for any accordingly
deviation unusual
signs and
symptoms that
needs further
monitoring.
● For collaboration
and continuation
of care to meet
the needs of the
patient
9/20/2023 Refer to Dr. M. Cinco For collaboration and Referred the patient to
At 7:45 AM continuation of care to Dr, M. Cinco
meet the needs of the
patient
For Hemodialysis To filter wastes and Referred the
tomorrow water from the blood, ordered tests to
as the kidneys did other members of
when they were the healthcare team
healthy and fully Explained the
functional. procedures and
Hemodialysis helps purpose of the
control blood pressure procedure to the
and balance important significant other
minerals such as Prepared the
potassium, sodium and patient for the
calcium in the blood. procedures
Reviewed values
and reported any
abnormal values
Monitored puncture
site (complete blood
count) for oozing or
hematoma
formation
Intravenous fluid to
follow: PNSS 500cc x 2 To help maintain ● Assessed the
hours the right fluid patient's vital
balance in the body signs before
To maintain infusion.
catheter patency by ● Verified the
preventing internal prescription and
luminal (inner ensured the
surface) occlusion right IV is given
to restore or to the right
maintain normal patient.
68
University of Saint Louis
Tuguegarao City, Cagayan 3500
70
University of Saint Louis
Tuguegarao City, Cagayan 3500
71
University of Saint Louis
Tuguegarao City, Cagayan 3500
72
University of Saint Louis
Tuguegarao City, Cagayan 3500
Administration.
Monitored for any
adverse effects.
Intravenous Fluid to
follow: PNSS 1 L x 12 To help maintain ● Assessed the
hours x 2 counts the right fluid patient's vital
balance in the body signs before
To maintain infusion.
catheter patency by ● Verified the
preventing internal prescription and
luminal (inner ensured the
surface) occlusion right IV is given
to restore or to the right
maintain normal patient.
fluid volume and ● IVF hooked,
electrolyte balance regulated at
when the oral route desired dose,
is not possible. and ensured IV-
useful for daily line patency.
maintenance of ● Continued
body fluids and monitoring
nutrition, and for during and after
rehydration the infusion
especially for
adverse effects.
DIAGNOSTIC EXAMINATIONS
LABORATORY RESULTS
HEMATOLOGY
Date Requested: September 12, 2023
Date/Time Released: September 12, 2023 5:06 PM
79
University of Saint Louis
Tuguegarao City, Cagayan 3500
malnutrition
Monocyte 0.04 0.02-0.06 Normal
Eosinophil 0.02 0.01-0.04 Normal
Basophil 0.00 0.00-0.01 Normal
Platelet Count 171 X10^9/L 150-400 Normal
81
University of Saint Louis
Tuguegarao City, Cagayan 3500
impairment
driven by
uremia,
inflammation or
malnutrition
Monocyte 0.07 0.02-0.06 Slightly elevated
but not
significant
Eosinophil 0.02 0.01-0.04 Normal
Basophil 0.00 0.00-0.01 Normal
Platelet Count 315 X10^9/L 150-400 Normal
CLINICAL CHEMISTRY
Date requested: September 25, 2023
Date/time released: September 26, 2023 2:27 AM
SI
EXAMINATION RESULT UNIT REFERENCE ANALYSIS
RANGE
Serum Glutamic 35.5 u/L Up to 45 Normal
Pyruvic
Transaminase/Alanin
e Aminotransferase
CLINICAL CHEMISTRY
Date requested: September 12, 2023
Date/time released: September 12, 2023 5:47 PM AM
SI CONVENTIONAL
EXAMINA RESU UNIT REFERE ANALY RESU UNI REFERE ANALY
TION LT NCE SIS LT T NCE SIS
RANGE RANGE
HBA1C: 6.0 % 4.2-6.5 Normal
Glycosylate
d
Hemoglobi
n
Creatinine 667.8 umol 58-110 Elevate 8.33 mg/ 0.66-1.25 Elevate
0 /L d due to dL d due to
decreas decreas
ed ed
82
University of Saint Louis
Tuguegarao City, Cagayan 3500
clearan clearan
ce by ce by
the the
kidney kidney
ELECTROLYTES
Sodium 100.5 mmo 135-155 Decreas 231.0 mg/ 310.5- Decreas
0 l/L ed due 3 dL 356.50 ed due
to fluid to fluid
overloa overloa
d or d or
diuretic diuretic
usage usage
Potassium 3.73 mmo 3.6-5.5 Normal 14.58 mg/ 14.08- Normal
l/L dL 21.51
Magnesium 0.80 mmo 0.7-1.0 Normal 1.94 mg/ 1.6-2.3 Normal
l/L dL
SI CONVENTIONAL
EXAMINA RESU UNIT REFERE ANALY RESU UNI REFERE ANALY
TION LT NCE SIS LT T NCE SIS
RANGE RANGE
ELECTROLYTES
Sodium 135.0 mmo 135-155 Normal 310.5 mg/ 310.5- Normal
0 l/L dL 356.50
Potassium 3.26 mmo 3.6-5.5 12.74 mg/ 14.08-
l/L dL 21.51
SI CONVENTIONAL
EXAMINA RESU UNIT REFERE ANALY RESU UNI REFERE ANALY
TION LT NCE SIS LT T NCE SIS
RANGE RANGE
ELECTROLYTES
Sodium 136.9 mmo 135-155 Normal 314.7 mg/ 310.5- Normal
0 l/L 1 dL 356.50
Potassium 3.44 mmo 3.6-5.5 Decreas 13.45 mg/ 14.08- Decreas
l/L ed due dL 21.51 ed due
to fluid to fluid
overloa overloa
d or d or
diuretic diuretic
83
University of Saint Louis
Tuguegarao City, Cagayan 3500
usage usage
Ionized 1.12 mmo 1.13-1.32 Slightly 4.48 mg/ 4.62-5.28 Slightly
Calcium l/L decreas dL decreas
ed but ed but
not not
significa significa
nt nt
SI CONVENTIONAL
EXAMINA RESU UNIT REFERE ANALY RESU UNI REFERE ANALY
TION LT NCE SIS LT T NCE SIS
RANGE RANGE
ELECTROLYTES
Sodium 135.2 mmo 135-155 Normal 310.8 mg/ 310.5- Normal
0 l/L 0 dL 356.50
Potassium 3.88 mmo 3.6-5.5 Normal 15.17 mg/ 14.08- Normal
l/L dL 21.51
SI CONVENTIONAL
EXAMINA RESU UNIT REFERE ANALY RESU UNI REFERE ANALY
TION LT NCE SIS LT T NCE SIS
RANGE RANGE
Creatinine 399.9 umol 58-110 Elevate 4.52 mg/ 0.66-1.25 Elevate
0 /L d due to dL d due to
decreas decreas
ed ed
clearan clearan
ce by ce by
the the
kidney kidney
ELECTROLYTES
Sodium 135.9 mmo 135-155 Normal 312.4 mg/ 310.5- Normal
0 l/L 1 dL 356.50
Potassium 3.98 mmo 3.6-5.5 Normal 15.56 mg/ 14.08- Normal
l/L dL 21.51
CLINICAL MICROSCOPY/PARASITOLOGY
Date requested: September 25, 2023
Date/time released: September 25, 2023 10:43 AM
84
University of Saint Louis
Tuguegarao City, Cagayan 3500
DISCHARGE PLAN
86